Organisation paid for research Program year 2025 Source: CMS Open Payments

MedStar

Neither a doctor nor a teaching hospital

Research payments

$269,925

19 payments

Through program year 2025, MedStar is reported as receiving $269,925 in research payments, across 19 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$15,975	2
2024	Research	$149,282	13
2023	Research	$104,668	4

Breakdown

Who paid Research payments · program years 2023–2025

Pfizer Inc. $112,408 5 payments
Endotronix, Inc. $107,077 2 payments
Exact Sciences Corporation $46,840 11 payments
Shockwave Medical, Inc $3,600 1 payment

Studies the money was for Research payments · program years 2023–2025

An Openlabel Multicenter Randomized Phase 3 Study of Firstline Encorafenib Plus Cetuximab With Or Without Chemotherapy Versus Standard of Care Therapy With A Safety Leadin of Encorafenib and Cetuximab Plus Chemotherapy in Participants With Metastatic Braf V600emutant Colorectal Cancer $112,408 5 payments
Proactive-Hf $107,077 2 payments
Tidal Study $17,880 6 payments
A Real World Study of Patients Under the Age of 50 Screened for Colorectal Cancer (CRC) Using Cologuard in the U.S. "Tidal $15,975 2 payments
2019-03 Tidal study $12,985 3 payments
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II $3,600 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.